Coriell Institute For Medical Research Inc
- Assets
- $27.6m
- Revenue
- $23.3m
- Investments
- $0.0
- Employees
- 110
- Location
- Camden, NJ
- Founding
- 12/1954
- Data as of
- 06/2022
- EIN
- 21-0672684
Organization Overview
Coriell Institute For Medical Research Inc is located in Camden, NJ. The organization was established in 1954. According to its NTEE Classification (U50) the organization is classified as: Biological & Life Sciences, under the broad grouping of Science & Technology and related organizations. As of 06/2022, Coriell Institute For Medical Research Inc employed 110 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Coriell Institute For Medical Research Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2022, Coriell Institute For Medical Research Inc generated $23.3m in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 3.9% each year. All expenses for the organization totaled $20.3m during the year ending 06/2022. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
GENERATE WORLD CLASS BIOMATERIALS AND CONDUCT GROUNDBREAKING RESEARCH.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE CORIELL INSTITUTE FOR MEDICAL RESEARCH IS A GLOBALLY RECOGNIZED LEADER IN BIOBANKING AND BIOMEDICAL RESEARCH. CORIELL IS HOME TO ONE OF THE WORLD'S MOST IMPORTANT BIOBANKS WHICH DISTRIBUTES BIOLOGICAL SAMPLES AND OFFERS RESEARCH AND BIOBANKING SERVICES TO SCIENTISTS AROUND THE WORLD. CORIELL IS THE TRUSTED STEWARD OF WORLD-RENOWNED COLLECTIONS FOR THE NATIONAL INSTITUTES OF HEALTH, DISEASE FOUNDATIONS AND COMMERCIAL CLIENTS. ALSO A LEADER IN GENOMIC AND EPIGENOMIC RESEARCH, CORIELL IS UNCOVERING THE WAYS OUR GENETIC MAKEUP AFFECTS OUR HEALTH, ESPECIALLY WITH REGARD TO CANCER, AGING, AND PERSONALIZED MEDICINE.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Dr Jean-Pierre Issa President/ceo | OfficerTrustee | 40 | $630,537 |
Robert Kiep III Chair | OfficerTrustee | 1 | $0 |
Marc Maser ESQ Vice Chair | OfficerTrustee | 1 | $0 |
Arnaud Bastien MD Trustee | Trustee | 1 | $0 |
Edward Viner MD Trustee | Trustee | 1 | $0 |
Frank Giordano Trustee | Trustee | 1 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Van Andel Institute Nci P50 Subaward - Research/lab Work | 6/29/22 | $493,272 |
University Of Florida Nih R01 Subaward - Research/lab Work | 6/29/22 | $251,513 |
University Of Md Baltimore Nci P50 Subaward - Research/lab Work | 6/29/22 | $244,016 |
Johns Hopkins University Nci P50 Subaward - Research/lab Work | 6/29/22 | $206,353 |
Cooper University Physicians - Cri Vivarium | 6/29/22 | $135,808 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $1,137 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $3,162,000 |
| All other contributions, gifts, grants, and similar amounts not included above | $54,354 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $3,217,491 |
| Total Program Service Revenue | $19,900,725 |
| Investment income | $83,936 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $755 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $23,280,611 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $1,589,575 |
| Compensation of current officers, directors, key employees. | $1,589,575 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $5,447,965 |
| Pension plan accruals and contributions | $449,057 |
| Other employee benefits | $1,557,123 |
| Payroll taxes | $524,832 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $141,451 |
| Fees for services: Accounting | $212,739 |
| Fees for services: Lobbying | $67,900 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $2,608,464 |
| Advertising and promotion | $0 |
| Office expenses | $575,913 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $3,710,832 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $127,856 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $1,343,448 |
| Insurance | $0 |
| All other expenses | $0 |
| Total functional expenses | $20,312,651 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $1,200 |
| Savings and temporary cash investments | $1,280,831 |
| Pledges and grants receivable | $4,003,360 |
| Accounts receivable, net | $762,814 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $98,066 |
| Prepaid expenses and deferred charges | $330,690 |
| Net Land, buildings, and equipment | $6,207,343 |
| Investments—publicly traded securities | $3,387,809 |
| Investments—other securities | $0 |
| Investments—program-related | $300,000 |
| Intangible assets | $0 |
| Other assets | $11,212,010 |
| Total assets | $27,584,123 |
| Accounts payable and accrued expenses | $1,168,678 |
| Grants payable | $0 |
| Deferred revenue | $102,518 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $4,675,500 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $10,559 |
| Total liabilities | $5,957,255 |
| Net assets without donor restrictions | $12,768,886 |
| Net assets with donor restrictions | $8,857,982 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $27,584,123 |